U.S. Stockpiles Two Bird Flu Vaccines
U.S. government health officials announced earlier this month that two bird flu vaccines are being stockpiled and will be available for shipment within weeks. They said that the bird flu stockpiling is part of their emergency preparations in the event the H5N1 virus, which now primarily infects wild birds, chickens and sometimes cows and other […]
BARDA Awards $9.27 Million Contract to Evaluate Oral Pill COVID Vaccine
Biotechnology firm Vaxart, Inc. announced on Jan. 19, 2024 that it received a $9.27 million contract from the U.S. Biomedical Advanced Research and Development Authority (BARDA) to fund preparations for a Phase IIb clinical trial to evaluate the company’s oral pill XXB COVID-19 vaccine candidate. The trial is expected to involve 10,000 participants and will […]
Federal Government Paid Media Outlets to Promote the COVID Vaccine
Opinion | After releasing my three-part series earlier this year showing how multiple media outlets refused to platform dissent on the COVID vaccine, I was asked on multiple podcasts why this was the case. Ideological groupthink, fear of exacerbating institutional distrust, and financial motives were on my list of potential explanations, but I did not have […]
U.S. Taxpayer Funded Initiative Trains Dentists to Push HPV Vaccine
In recent years, government health agencies, cancer societies, as well as the American Dental Association (ADA), have attempted to recruit dentists to advocate for patients to get the human papillomavirus (HPV) vaccine to prevent oral cancers. An HPV Vaccine Roundtable initiative, funded largely by the U.S. Centers for Disease Control and Prevention (CDC), advises dentists […]
Nearly 50 Percent of Federal Panelists Making Dietary Recommendations Have Money Ties to Food Industry
About half of the members of a U.S. federal government panel that shapes dietary recommendations in the United States have significant financial ties to big agriculture, processed food companies, weight loss companies, pharmaceutical companies, and other corporate organizations a recent report reveals. An additional four committee members had “possible” financial conflicts of interest.1 The Dietary […]
Pfizer Will Charge Patients $1,390 for COVID Anti-Viral Paxlovid
Pfizer, Inc. plans to charge consumers more than double the price charged to the U.S. government for its COVID-19 anti-viral drug nirmatrelvir-ritonavir, sold under the brand name Paxlovid. A five-day course of the drug to treat COVID will soon cost patients $1,390. According to researchers, it costs Pfizer $13 to manufacture the supply of pills […]